Sign In
Buy RPID
$1.96
+0 (+0%)
At Close: Jun 03, 2026
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
09:55pm, Monday, 18'th May 2026
LEXINGTON, Mass. , May 18, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. ("Rapid Micro Biosystems") (Nasdaq: RPID), an innovative life sciences technology company providing mission-critical au
Rapid Micro Biosystems Q1 Earnings Call Highlights
12:14am, Thursday, 14'th May 2026
Rapid Micro Biosystems NASDAQ: RPID reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while mana
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
09:10pm, Wednesday, 13'th May 2026
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
07:11pm, Wednesday, 13'th May 2026
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.26 per share a year ago.
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
04:25pm, Wednesday, 13'th May 2026
LEXINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation
Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026
04:15pm, Wednesday, 06'th May 2026
LEXINGTON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation
What Makes Rapid Micro Biosystems (RPID) a New Buy Stock
01:01pm, Tuesday, 14'th Apr 2026
Rapid Micro Biosystems (RPID) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Rapid Micro Biosystems Q4 Earnings Call Highlights
01:14am, Saturday, 14'th Mar 2026
Rapid Micro Biosystems (NASDAQ: RPID) reported fourth-quarter and full-year 2025 results highlighting record quarterly revenue, increased system placements, and expanding recurring revenue, while also
Rapid Micro Biosystems: Big Pharma Adoption Driving Growth
09:30am, Friday, 13'th Mar 2026
Rapid Micro Biosystems, Inc. posted strong FY25 revenue growth, driven by Growth Direct system placements, but remains unprofitable with a $47M net loss. RPID's growth hinges on large multi-system ord
Rapid Micro Biosystems, Inc. (RPID) Q4 2025 Earnings Call Transcript
10:42am, Thursday, 12'th Mar 2026
Rapid Micro Biosystems, Inc. (RPID) Q4 2025 Earnings Call Transcript
Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
07:00am, Thursday, 12'th Mar 2026
Reports record fourth quarter 2025 total revenue of $11.3 million , representing 37% growth compared to fourth quarter 2024 Reports full year 2025 total revenue of $33.6 million , representing 20%
Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform
06:30am, Thursday, 12'th Mar 2026
Companies deepen partnership to advance automated, integrated microbiology quality control Companies deepen partnership to advance automated, integrated microbiology quality control
Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum
04:45pm, Tuesday, 10'th Mar 2026
LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automati
Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference
04:15pm, Thursday, 26'th Feb 2026
LEXINGTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automatio
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
04:15pm, Tuesday, 24'th Feb 2026
LEXINGTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automatio
